Works by Nguyen, Andrew


Results: 215
    1
    2
    3
    4
    5
    6
    7

    Assessment of Blood Loss during Neuroendovascular Procedures.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 677, doi. 10.3390/jcm13030677
    By:
    • Goutnik, Michael;
    • Nguyen, Andrew;
    • Fleeting, Chance;
    • Patel, Aashay;
    • Lucke-Wold, Brandon;
    • Laurent, Dimitri;
    • Wahbeh, Tamara;
    • Amini, Shawna;
    • Al Saiegh, Fadi;
    • Koch, Matthew;
    • Hoh, Brian;
    • Chalouhi, Nohra
    Publication type:
    Article
    8
    9
    10
    11
    12

    Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 1, p. 67, doi. 10.7326/M22-2699
    By:
    • Harrison, Luke B.;
    • Bergeron, Geneviève;
    • Cadieux, Geneviève;
    • Charest, Hugues;
    • Fafard, Judith;
    • Levade, Inès;
    • Blais, Antoine Cloutier;
    • Huchet, Emmanuelle;
    • Trottier, Benoît;
    • Vlad, Dragos;
    • Szabo, Jason;
    • Thomas, Réjean;
    • Poulin, Sébastien;
    • Greenaway, Christina;
    • Zaharatos, Gerasimos J.;
    • Oughton, Matthew;
    • Chakravarti, Arpita;
    • Pilarski, Robert;
    • Bui-Nguyen, Andrew;
    • Benomar, Khadija
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Identification of Alzheimer's disease in Veteran patients using clinical notes from electronic health records.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.077293
    By:
    • Miller, Donald R;
    • Aguilar, Byron J.;
    • Li, Xuyang;
    • Shishova, Ekaterina;
    • Jasuja, Guneet;
    • Berlowitz, Dan;
    • Morin, Peter J;
    • O'Connor, Maureen K.;
    • Nguyen, Andrew H.;
    • Christiansen, Cindy;
    • Zhang, Haixin;
    • Monfared, Amir Abbas Tahami;
    • Zhang, Quanwu;
    • Xia, Weiming
    Publication type:
    Article
    21

    Comparative identification of Veterans with mild cognitive impairment or Alzheimer's disease extracted from clinical notes and administrative data.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.075975
    By:
    • Berlowitz, Dan;
    • Aguilar, Byron J.;
    • Li, Xuyang;
    • Shishova, Ekaterina;
    • Jasuja, Guneet;
    • Morin, Peter J;
    • Miller, Donald R;
    • O'Connor, Maureen K.;
    • Nguyen, Andrew H.;
    • Zhang, Raymond;
    • Monfared, Amir Abbas Tahami;
    • Zhang, Quanwu;
    • Xia, Weiming
    Publication type:
    Article
    22

    Estimating the prevalence of mild cognitive impairment from clinical notes in U.S. Veterans.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.075629
    By:
    • Jasuja, Guneet;
    • Li, Xuyang;
    • Aguilar, Byron J.;
    • Shishova, Ekaterina;
    • Morin, Peter J;
    • Berlowitz, Dan;
    • Miller, Donald R;
    • O'Connor, Maureen K.;
    • Nguyen, Andrew H.;
    • Zhang, Raymond;
    • Monfared, Amir Abbas Tahami;
    • Zhang, Quanwu;
    • Xia, Weiming
    Publication type:
    Article
    23

    Building a neuropsychiatric testing database for veterans with mild cognitive impairment and Alzheimer's disease with unstructured electronic health records.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.075390
    By:
    • Li, Xuyang;
    • Chen, Jinying;
    • Aguilar, Byron J.;
    • Shishova, Ekaterina;
    • Morin, Peter J;
    • Berlowitz, Dan;
    • Miller, Donald R;
    • O'Connor, Maureen K.;
    • Nguyen, Andrew Huy;
    • Zhang, Raymond;
    • Monfared, Amir Abbas Tahami;
    • Zhang, Quanwu;
    • Xia, Weiming
    Publication type:
    Article
    24
    25
    26
    27
    28

    The Tyr Phenomenon: A Hypocalcemic Response in High-Volume Treatment Responders to <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1412, doi. 10.2967/jnumed.123.265759
    By:
    • Kumar, Shejil;
    • Crumbaker, Megan;
    • Harvey, Christopher;
    • Pathmanandavel, Sarennya;
    • John, Nikieth;
    • Swiha, Mina M.;
    • McDonald, Michelle M.;
    • Clifton-Bligh, Roderick;
    • 7–, Adrian Lee;
    • Bastick, Patricia;
    • Counter, William;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    29

    <sup>177</sup>Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing <sup>177</sup>Lu-PSMA-I&T Therapy.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 410, doi. 10.2967/jnumed.122.264677
    By:
    • John, Nikeith;
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Counter, William;
    • Bao Ho;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Poole, Aron;
    • Hickey, Adam;
    • Agrawal, Shikha;
    • Perkins, Gary;
    • Kallinen, Annukka;
    • Eslick, Enid;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    30

    Evaluation of <sup>177</sup>Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 221, doi. 10.2967/jnumed.122.264398
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Bao Ho;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Hickey, Adam;
    • Eu, Peter;
    • Stockler, Martin;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    31

    The Prognostic Value of Posttreatment <sup>68</sup>Ga-PSMA-11 PET/CT and <sup>18</sup>F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 69, doi. 10.2967/jnumed.122.264104
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Nguyen, Andrew;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    32

    <sup>177</sup>Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264677
    By:
    • John, Nikeith;
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Counter, William;
    • Bao Ho;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Poole, Aron;
    • Hickey, Adam;
    • Agrawal, Shikha;
    • Perkins, Gary;
    • Kallinen, Annukka;
    • Eslick, Enid;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    33

    Evaluation of <sup>177</sup>Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264398
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Ho, Bao;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Hickey, Adam;
    • Eu, Peter;
    • Stockler, Martin;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    34

    The prognostic value of post-treatment PSMA and FDG PET/CT in metastatic, castration-resistant prostate cancer treated with 177LuPSMA-617 and NOX66 in a phase I/II trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264104
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Nguyen, Andrew;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    35

    <sup>177</sup> Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264677
    By:
    • John, Nikeith;
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Counter, William;
    • Bao Ho;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Poole, Aron;
    • Hickey, Adam;
    • Agrawal, Shikha;
    • Perkins, Gary;
    • Kallinen, Annukka;
    • Eslick, Enid;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    36

    Evaluation of <sup>177</sup>Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective <sup>177</sup>Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264398
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Ho, Bao;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Hickey, Adam;
    • Eu, Peter;
    • Stockler, Martin;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Nguyen, Andrew;
    • Emmett, Louise
    Publication type:
    Article
    37

    The prognostic value of post-treatment PSMA and FDG PET/CT in metastatic, castration-resistant prostate cancer treated with 177LuPSMA-617 and NOX66 in a phase I/II trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264104
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Nguyen, Andrew;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    38

    The prognostic value of post-treatment PSMA and FDG PET/CT in metastatic, castration-resistant prostate cancer treated with 177LuPSMA-617 and NOX66 in a phase I/II trial (LuPIN).

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264104
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Nguyen, Andrew;
    • Yam, Andrew O.;
    • Wilson, Peter;
    • Niman, Remy;
    • Ayers, Maria;
    • Sharma, Shikha;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Stockler, Martin R.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    39

    <sup>177</sup>Lutetium-PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castration-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262552
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Yam, Andrew O.;
    • Nguyen, Andrew;
    • Rofe, Christopher;
    • Hovey, Elizabeth;
    • Gedye, Craig;
    • Kwan, Edmond M.;
    • Hauser, Christine;
    • Azad, Arun A.;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    40

    <sup>177</sup>Lutetium-PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castration-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262552
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Yam, Andrew O.;
    • Nguyen, Andrew;
    • Rofe, Christopher;
    • Hovey, Elizabeth;
    • Gedye, Craig;
    • Kwan, Edmond M.;
    • Hauser, Christine;
    • Azad, Arun A.;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    41

    <sup>177</sup>Lutetium-PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castration-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262552
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Yam, Andrew O.;
    • Nguyen, Andrew;
    • Rofe, Christopher;
    • Hovey, Elizabeth;
    • Gedye, Craig;
    • Kwan, Edmond M.;
    • Hauser, Christine;
    • Azad, Arun A.;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    42

    <sup>177</sup>Lutetium-PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castration-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262552
    By:
    • Pathmanandavel, Sarennya;
    • Crumbaker, Megan;
    • Yam, Andrew O.;
    • Nguyen, Andrew;
    • Rofe, Christopher;
    • Hovey, Elizabeth;
    • Gedye, Craig;
    • Kwan, Edmond M.;
    • Hauser, Christine;
    • Azad, Arun A.;
    • Eu, Peter;
    • Martin, Andrew J.;
    • Joshua, Anthony M.;
    • Emmett, Louise
    Publication type:
    Article
    43

    3 year freedom from progression following <sup>68</sup>GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi‐center trial.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.235028
    By:
    • Emmett, Louise;
    • Tang, Reuben;
    • Nandurkar, Rohan;
    • Hruby, George;
    • Roach, Paul;
    • Watts, Jo Anne;
    • Cusick, Thomas;
    • Kneebone, Andrew;
    • Bao Ho;
    • Chan, Lyn;
    • van Leeuwen, Pim J.;
    • Scheltema, Matthijs J.;
    • Nguyen, Andrew;
    • Charlotte Yin;
    • Scott, Andrew;
    • Tang, Colin;
    • McCarthy, Michael;
    • Fullard, Karen;
    • Roberts, Matthew;
    • Francis, Roslyn
    Publication type:
    Article
    44
    45
    46

    Prediction of the Structural Color of Liquid Crystals via Machine Learning.

    Published in:
    Liquids (2673-8015), 2023, v. 3, n. 4, p. 440, doi. 10.3390/liquids3040028
    By:
    • Nguyen, Andrew T.;
    • Childs, Heather M.;
    • Salter, William M.;
    • Filippas, Afroditi V.;
    • McInnes, Bridget T.;
    • Senecal, Kris;
    • Lawton, Timothy J.;
    • D'Angelo, Paola A.;
    • Zukas, Walter;
    • Alexander, Todd E.;
    • Ayotte, Victoria;
    • Zhao, Hong;
    • Tang, Christina
    Publication type:
    Article
    47
    48
    49
    50